The Auresine technology was promoted by Izabela Sabała during 3rd AMR Conference in Berlin. The ARM Conference aimed at bringing together SMEs, start-ups, big pharma, academia and investors to discuss strategies of transferring newly developed antimicrobials to the market. Our latest results were shown on the poster “Bacteriolytic enzyme Auresine – a new weapon against staphylococcus“. The presented results interested many potential collaborators and investors.